Goldman Sachs raise (NASDAQ:AAPL) price target ahead of next iPhone release

in NASDAQ by

Goldman Sachs has raised its earnings forecasts for Apple as it expects the upcoming release of the 10th anniversary iPhone to boost sales

Apple Inc. (NASDAQ:AAPL) has received another target price hike – this time from Goldman Sachs, which expects the tech giant will unveil its first US$1,000 iPhone in September.

The iPhone maker became the first company to see its market capitalisation surpass US$800bn on Monday after Drexel Hamilton raised its target price to US$202 a share from US$185, giving the company an estimated US$1trn valuation.

Now Goldman Sachs has joined in on the Apple love, lifting its target price to US$170 from US$164bn and reiterating a ‘buy’ rating on the stock.

The bank said Apple’s pricier iPhones to be released later this year, including a 128 gigabyte model for at US$999 and a 256 gigabyte model for US$1,099, could boost average selling prices and gross margins.

Goldman believes this would “drive meaningful upside” to the stock and raised its 2018 and 2019 earnings estimates to reflect its positive outlook.

Shares in Apple rose 0.90% to US$155.35 in early US trading.

Apple’s shares have gained 16% in the past three months and 70% in the past year, outperforming US indices S&P 500 and the Dow Jones Industrial Average.

Drexel Hamilton expects Apple’s valuation will reach $1T as investors begin to realise its growth potential. Brian White, an analyst at Drexel, said Apple’s future prospects look solid with the release of the iPhone8 in September, along with other new innovations and an increase in its capital return programme by $50B by the end of March.

Nvidia Corp (NASDAQ:NVDA) Shares Explode As Demand Grows For AI Chips

in NASDAQ by

At the company’s annual GPU Technology Conference (GTC), NVIDIA took the giant step toward an accelerator processor architecture customized for artificial intelligence (AI). NVIDIA pioneered the development of artificial neural networks through deep learning with the company’s GPUs and CUDA software platform. While the market is now flush with other solutions, NVIDIA accounts for the clear majority of deep learning networks in use today. The company is engaged with over 40,000 companies and over a half a million Keep Reading

Array Biopharma Inc (NASDAQ:ARRY) Shares Rise Following Top-Line Results From Part 2 Of it’s Phase III Study

in NASDAQ by

Array Biopharma Inc (NASDAQ:ARRY) Shares Rise Following Top-Line Results From Part 2 Of it’s Phase III Study  following positive top-line results from part 2 of its phase III study of Binimetinib plus Encorafenib for BRAF-mutant melanoma.

In the phase III study, dubbed COLUMBUS, the median progression free survival for patients on combination of Binimetinib plus Encorafenib was 12.9 months versus 9.2 months for patients on Encorafenib alone.

Binimetinib and Encorafenib are investigational medicines of Array BioPharma.

The Company is planning to file an NDA for Binimetinib plus Encorafenib in June or July 2017.


INC Research Holdings, Inc. (NASDAQ:INCR) to merge with inVentiv Health

in NASDAQ by

INC Research Holdings, Inc a Phase I-IV Contract Research Organization or CRO, Wednesday announced that it has agreed to merge with inVentiv Health, Inc., a privately held, global CRO and Contract Commercial Organization or CCO.

The Boards of Directors of both companies have unanimously approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock transaction, creating a biopharmaceutical solutions organization.

The transaction values inVentiv at an enterprise value of approximately $4.6 billion, based upon the closing price of INC Research common stock on Tuesday. The combined company would be at an enterprise value of approximately $7.4 billion.


Herborium Group inc (OTC:HBRM) Over 10,000% Upside Potential in 2017

Herborium Group, Inc. is a Botanical Therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company’s business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high- cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women’s health and selected sexual disorders resulting from cardiovascular disease, use of anti- depressants, diabetes, surgical procedures, and other issues. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

Keep Reading

Apple inc (NASDAQ:AAPL) Could Be a Major Player in The Transport Industry

in NASDAQ by

UBS’ equity research team circulated a note to clients on May 10 to share what they learned from speaking with Apple expert, Horace Dediu.

The biggest takeaway: “Transportation is Apple’s future.”

The analyst was referring to Apple’s “Project Titan,” which is its self-driving car division.

“Project Titan is likely to be a transportation platform—not a car but the entire experience,” the note said. “Jony Ive and Marc Newson are interested in car design, both exterior and interior.”

UBS said the experts it had spoken to thought car ownership will plummet with autonomous driving.

“Then who is going to own all these cars? It might be Apple, one plausible reason to keep a large cash balance,” the note said. “For now the company is building expertise in core sensor, driving, and mapping technologies.”

Mr. Dediu is a former software engineer and developer manager, turned technology analyst with an emphasis on Apple research. He has an MBA from Harvard Business School and an MS in Engineering from Tufts University.



Florida Congressmen Introduce Bill to Make Pot Easier to Get


Two Florida Congressmen, Matt Gaetz (R) and Darren Soto (D), introduced legislation in the U.S. House of Representatives that would reclassify marijuana as a Schedule III drug. If the bill were to become law (doubtful, but not impossible), the new classification would make it easier for people to obtain medical marijuana and easier for researchers to obtain cannabis for further study. Keep Reading

Tesla Motors (NASDAQ:TSLA) passed General Motors Co. (NYSE: GM) to take the top spot with a market cap of $50.9B


Tesla Motors (NASDAQ:TSLA) passed General Motors Co. (NYSE:GM) to take the top spot with a market cap of $50.9 billion. GM sold just over 10 million cars worldwide last year. Tesla sold fewer than 100,000.

To Get Our Stock & Option Alerts On $TSLA , Subscribe to Our NEWSLETTER NOW

AT&T Inc. (NYSE: T) agreed to acquire this 5G Technology for $1.6B

in NYSE by

AT&T Inc. (NYSE: T) announced this morning that it has agreed to acquire Straight Path Communications Inc. (NYSEMKT: STRP) in a deal totaling $1.6 billion, including licenses and liabilities. The all-stock deal values Straight Path at $95.53 per AT&T share.

According to AT&T, the acquisition includes 735 millimeter-wave (mmWave) licenses in the 39 GHz band and 133 licenses in the 28 GHz band and covers the entire United States, including the top 40 markets. mmWave technology is one of the cornerstones upon which next generation high-speed 5G networks will be built.

To Get Our Stock & Option Alerts On $T , Subscribe to Our NEWSLETTER NOW

eBay to Improve Delivery Options by Adding Guaranteed Delivery

in NASDAQ by

eBay plans to begin a guaranteed delivery service in the summer in the US that will be initially for 20 million eligible items, it said last month.

Guaranteed delivery will provide customers with more precise delivery deadlines of three days or less on many items for free and the option to search products by delivery days within one day and two days. eBay said If an item doesn’t arrive by the delivery date, it will “make it right.” Shares were little changed in recent midday trade.

To Get Our Stock & Option Alerts On $EBAY , Subscribe to Our NEWSLETTER NOW

1 2 3 15
Go to Top